Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BoostMe: Early Prime-Boost Measles Schedule
NCT06667206Phase 2Recruiting
- Sponsor
- University of Oxford
- Start
- Nov 2023
- Primary completion
- May 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Measles rubella vaccine in measles and rubella (3 arms), sponsored by University of Oxford. Primary endpoints: Protective measles antibody concentrations at 2.5 years of age, Local and systemic reactions and 1 more. Started Nov 2023; status: recruiting.
02
Drugs
Measles rubella vaccine
03
Conditions
measlesrubella
Beyond the preview
Go deeper on NCT06667206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06667206.